Question 1

What kind of company is Kosei Pharmaceutical Co., Ltd.?

Accepted Answer

A:Kosei Pharmaceutical Co., Ltd. is a long-established Japanese pharmaceutical wholesaler and specialized trading house headquartered in Osaka, established in 1952. With over 70 years of heritage, the company is a global leader that integrates a robust domestic foundation with the cutting-edge digital platform, 'synapse.'Corporate Attributes & Core CompetenciesProven Reliability & Market Presence: As an independent wholesaler, we maintain a powerful network of approximately 12,000 medical institutions and pharmacies across Japan.Pioneer in Global Distribution: We operate 'synapse,' a proprietary cross-border platform designed to connect the Japanese pharmaceutical market with the world, serving as a vital bridge for the stable supply of high-quality medicines to global healthcare settings.Strong Governance & Financial Stability: As a wholly-owned subsidiary of Clinphar Inc. (Tokyo Stock Exchange: 432A), we operate with the highest standards of transparency and regulatory compliance required of a publicly-listed group.Specialized Supply Chain Capabilities: We offer optimized domestic and international logistics, specializing in rapid response to urgent medical needs and the handling of medications requiring strict GDP-compliant cold chain management.Corporate ProfileOfficial Name: Kosei Pharmaceutical Co., Ltd.Established: July 1952 (Over 70 years of operation)Headquarters: 5th Floor, OMM Building, 1-7-31 Otemae, Chuo-ku, Osaka, JapanPresident & CEO: Kohei TodaParent Company: Clinphar Inc. (TSE: 432A)

Question 2

What are PMDA Standards, and what specific requirements do they include?

Accepted Answer

A:'PMDA Standards' is a collective term for the regulations and guidelines established by the Pharmaceuticals and Medical Devices Agency (PMDA) and the Ministry of Health, Labour and Welfare (MHLW). These standards are designed to ensure the Quality, Efficacy, and Safety of all pharmaceuticals and medical devices distributed within Japan.Structural Understanding of the Regulatory FrameworkPMDA Standards encompass a comprehensive set of rules covering the entire product lifecycle:Standards for Manufacturing and Quality Control (GxP):GMP (Good Manufacturing Practice): Standards for manufacturing control and quality control of products.GQP (Good Quality Practice): Standards for quality control of the marketing authorization holder (MAH).Benchmarks for Approval and Conformity Assessment:The Japanese Pharmacopoeia (JP): The official compendium of standards for the properties and quality of drugs.Essential Principles: Requirements regarding the safety and performance that medical devices must satisfy.Individual Approval/Certification Standards: Specific review guidelines established for particular diseases or product categories.Post-Marketing Safety ManagementGVP (Good Vigilance Practice): Standards for post-marketing safety management to monitor adverse effects and ensure patient safety.Professional Advice for Importers and Sourcing PartnersConformity for the Japanese Market: When introducing overseas products to Japan, proof of conformity to these PMDA Standards is mandatory. In particular, the GMP Inspection of manufacturing facilities is a critical and rigorous step in the approval process.Tracking the Latest Updates: Standards and guidelines are frequently updated to align with scientific progress. For the latest review policies regarding a specific product, we recommend checking the official PMDA website or consulting our regulatory specialists via Messages.

Question 3

What kind of company is Kosei Pharmaceutical Co., Ltd.?

Accepted Answer

A:Kosei Pharmaceutical Co., Ltd. is a premier Japanese pharmaceutical wholesaler and specialized trading house established in 1952. With over 70 years of history, the company is a global leader in supplying high-quality Japanese pharmaceuticals to the international market.Corporate Profile & Strategic StrengthsCore Business Integration: Combines a robust domestic foundation (trading with approx. 12,000 medical institutions in Japan) with an extensive global supply chain reaching over 50 countries.Proven Track Record: Maintains a vast network of over 70,000 corporate and medical partners worldwide.Specialized ExpertiseExporting Japanese-origin pharmaceuticals.Sourcing Orphan Drugs and Oncology medications.Operation of the global procurement platform 'synapse'.Corporate Governance: A wholly-owned subsidiary of Clinifer Co., Ltd. (Tokyo Stock Exchange: 432A). This ensures the highest standards of financial transparency and regulatory compliance.

Question 4

What are the pricing criteria and delivery terms for quotations?

Accepted Answer

A:Quotations issued on 'synapse' are, as a general rule, calculated based on 'EXW' (Ex Works) terms.Trade Terms & Price CompositionStandard Incoterms (EXW): Prices reflect the cost of the products at the point of pickup from our warehouse (e.g., Osaka, Japan). This baseline price does not include international freight, customs duties, taxes, or insurance.Shipping & Logistics OptionsCustom Shipping Quotes: Based on your registered shipping address, we can calculate and include international shipping costs (Air, Sea, etc.) as a separate line item in your quotation.Buyer-Arranged Pickup: We also accommodate pickups arranged by your designated freight forwarder.Quality Maintenance Costs: The cost of rigorous storage and handling under GDP (Good Distribution Practice) standards within our warehouse is already included in the quoted product price.

Question 5

Can you handle products requiring strict temperature control (Cold Chain), such as 2℃ to 8℃ storage?

Accepted Answer

A:Yes. We provide secure international transportation solutions using state-of-the-art Cold Chain technology to maintain a consistent 2℃ to 8℃ environment throughout the journey.Cold Chain Solutions & Quality AssuranceHigh-Performance Specialized Containers: We utilize advanced vacuum-insulated containers (e.g., va-Q-tec) and thermal packaging designed to maintain stable temperatures for extended periods during international transit.Real-time Temperature Monitoring: Temperature Data Loggers can be included in your shipment to record thermal conditions throughout the flight and inland transit. This provides empirical proof of quality and ensures no temperature deviations occurred upon arrival.GDP-Compliant Operations: From our warehouse in Japan to your designated global destination, all handling is conducted under strict EU GDP (Good Distribution Practice) standards.Customized Logistics Design: We propose the optimal packaging configuration based on the shipping route, estimated transit time, and the climatic conditions of the destination. Please consult with our specialists during the quotation process for specific requirements.

Question 6

How long will it take for the requested pharmaceuticals to reach me?

Accepted Answer

A:The lead time for procurement varies by product. Please refer to the specific delivery date provided in your 'Quotation Response.'Transparency of Delivery Information and Variability FactorsHow to Check Your Delivery DateAfter you submit a quotation request, we verify the stock status with our suppliers and provide an 'Estimated Lead Time.' You can find this information on the details page of your 'Quotes' history.Why Lead Times Vary by ProductIn-stock Items: If the product is in our warehouse or a partner facility, shipment preparation will typically be completed within a few business days after payment confirmation.On-Request Items: For products that must be sourced directly from the manufacturer, it may take 1 to 2 weeks (or longer for certain items) for the stock to arrive at our facility.Rare or Cold-Chain Items: Products requiring specialized procurement channels or high-performance thermal packaging (e.g., va-Q-tec) may require additional adjustment time.Important Considerations Regarding DeliveryThe Starting Point: Please note that the lead time is calculated from the 'Date of Payment Confirmation,' not from the date the quote was requested.Fluctuation Risks: Due to potential drug shortages in the global market, delivery may occasionally be delayed or the product may become unavailable after the quote is issued. In such cases, we will immediately update you via Messages.

synapse.FAQ

About synapse

Account

Features

RFQ

Payment

Logistics